Identification of Drug and Vaccine Targets in Highly Mutant Clostridium botulinum B1 okra by Subtractive Genomics

Authors

  • Koteswara Reddy G
  • Nagamalleswara Rao K

Keywords:

Clostridium botulinum B1 okra strain, subtractive genomics approach, drug and vaccine targets

Abstract

In the present work subtractive genomics approach is used to identify vaccine and drug targets of Clostridium botulinum B1 okra strain to speed up the rational drug and vaccine design. It revealed that out of 3292 coding sequences of the pathogen, 215 represent essential genes that have no human homolog.  Further analysis was done for 215 genes by the protein sequence sub-cellular localization database, in which 33 genes were identified as plasma membrane gene products which are possibly exposed on the pathogen surface. These 33 gene products are identified as potential drug and vaccine targets for the pathogen.

 

Author Biography

  • Koteswara Reddy G

    Asst.Professor

    Department of Biotechnology, Bapatla Engineering College, Bapatla-522 101, A.P, India

     

Downloads

Published

2012-10-26

Issue

Vol. 1 No. 2 (2012)

Section

Research Articles

License

COPYRIGHT NOTICE

 

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.